Literature DB >> 25619281

Successful delivery in a patient with clinically amyopathic dermatomyositis during pregnancy despite first-trimester acute exacerbation of interstitial lung disease.

Moeko Ochiai1, Eri Sato1, Eiichi Tanaka1, Mari Tochihara1, Yoko Shimizu1, Hikota Osawa1, Kumi Sidara1, Naoki Sugimoto1, Daisuke Hoshi1, Yasushi Kawaguchi1, Atsuo Taniguchi1, Hisashi Yamanaka1.   

Abstract

A 37-year-old woman with rheumatoid arthritis and interstitial lung disease (ILD) developed clinically amyopathic dermatomyositis (CADM) after achieving pregnancy through in vitro fertilization. She was given oral prednisolone, which improved her respiratory status, and delivered a healthy baby at 35 weeks' gestation. There are few reports of successful outcomes for CADM during pregnancy; to the best of our knowledge, this is the first report of successful delivery in a patient with both CADM and ILD.

Entities:  

Keywords:  Aminoacyl-tRNA; Anti-EJ; Clinically amyopathic dermatomyositis; Interstitial lung disease; Pregnancy; synthetases

Mesh:

Year:  2015        PMID: 25619281     DOI: 10.3109/14397595.2014.975906

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

Review 1.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.

Authors:  Cuihong Chen; Yulan Chen; Qin Huang; Qiu Hu; Xiaoping Hong
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

3.  Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.

Authors:  Yuhei Ito; Yoshiki Yamamoto; Yasuo Suzuki; Kentaro Noda; Ayako Nakajima
Journal:  Intern Med       Date:  2021-07-30       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.